Uterine fibroids
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with uterine fibroids who meet the surgical criteria. 2.Aged 18 and above but below 45, those who firmly request to retain the uterus. 3.Patients planning to undergo laparoscopic removal of uterine fibroids. 4.Those who understand the purpose, procedures, possible risks of this trial, voluntarily participate in this study, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients whose overall condition cannot tolerate laparoscopic surgery. 2.Patients with multiple fibroids, with a total number of fibroids >= 4 and a maximum diameter of a single fibroid >= 10cm. 3.Patients who require surgeries other than laparoscopic fibroid removal surgery (excluding pelvic adhesion release, excision of mesosalpinx cysts less than 2cm, and excision/electrocoagulation of superficial intraperitoneal lesions). 4.Considering the possibility of malignant transformation of uterine fibroids preoperatively. 5.Preoperative diagnosis is unclear and needs to be differentiated from ovarian tumors. 6.History of previous lower abdominal surgery or severe pelvic or abdominal adhesions. 7.Presence of untreated infectious sexual diseases, including but not limited to vaginitis, cervicitis, and pelvic inflammatory disease. 8.Patients who cannot understand the research protocol, cooperate with the study procedures and follow-up, and any other patients deemed unsuitable for participation in this study by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total surgical time;Time of Uterine Fibroid Removal; | — |
Secondary
| Measure | Time frame |
|---|---|
| Placement Success Rate;Intraoperative Rupture and Leakage Rate;Gynecologic Surgeon Satisfaction with the Procedure (Appendix 1);Total Weight of Uterine Fibroid Fragments Removed;Weight and Number of Residual Tissue Fragments in the Abdominal Cavity;Cytological examination of peritoneal lavage fluid before and after morcellation for the presence of spindle cells or tumor cells.;Intraoperative Blood Loss;Intraoperative Complications (Perforation of the endometrium, injury to major blood vessels, nerves, and organs, etc.);Postoperative Complications (Postoperative major bleeding, urinary retention);Preoperative and Postoperative Hemoglobin Levels;Postoperative Fibroid Recurrence Rate;Intraoperative and Postoperative Blood Transfusion Rate;Postoperative Length of Hospital Stay and Hospitalization Costs; | — |
Countries
China
Contacts
Affiliated hangzhou first people's hospital, zhejiang university school of medicine